미용의학 시장 규모, 점유율 및 동향 분석 보고서 : 시술별, 용도별, 지역별 및 부문별 예측(2026-2033년)

Aesthetic Medicine Market Summary

The global aesthetic medicine market size was estimated at USD 98.8 billion in 2025 and is projected to reach USD 240.0 billion by 2033, growing at a CAGR of 11.9% from 2026 to 2033. This growth can be attributed to the increasing adoption of minimally invasive and noninvasive procedures, coupled with growth in the population prone to experiencing signs of aging.

As per the ISAPS report, approximately 17.42 million surgical procedures and 20.54 million non-surgical procedures were performed in 2025. Moreover, technological advancements, such as minimally invasive techniques, laser treatments, and injectables such as Botox and dermal fillers, have made cosmetic procedures safer and more accessible, encouraging more individuals to consider them.

In addition, the growth of healthcare tourism and the availability of well-trained specialists in emerging markets support the expansion of this market. The section below outlines the key factors driving the growth of aesthetic medicines, highlighting the rising demand for minimally invasive procedures, a growing generic population, and the rising use of aesthetic medicines by men due to changing beauty standards. It also examines the role of social media platforms in changing and idealizing beauty standards.

Rising Demand for Minimally Invasive Procedures

The market is driven by the increasing popularity of minimally invasive, non-surgical options such as botulinum toxin injections, dermal fillers, and laser treatments. Consumers opt for these procedures as they offer benefits such as shorter recovery times, lower risks, lower costs, and faster healing than traditional surgeries. Ongoing improvements in device technology and injectable products have also increased the safety and effectiveness of these treatments. In November 2025, Allergan Aesthetics showcased clinical data and expanded indications for BOTOX Cosmetic and hyaluronic acid dermal fillers at the American Society for Dermatologic Surgery (ASDS) Annual Meeting. The data highlighted high patient satisfaction and safety, as well as growing adoption of non-surgical injectable treatments.

Growing Geriatric Population Driving Demand for Anti-Aging Aesthetic Treatments

The increasing geriatric population across the globe is expected to drive the market. Major economies are undergoing a demographic shift due to a rapidly aging population, and the demand for cosmetic solutions is growing to combat the visible signs of aging and maintain a youthful appearance. This has led to a significant surge in demand for aesthetic medicines that effectively reduce wrinkles, fine lines, and other age-related concerns. In November 2025, Galderma presented data on a range of pioneering Restylane hyaluronic acid (HA) injectables, Restylane Lyft, Restylane Contour, and Restylane Skinboosters, which highlighted that these treatments effectively improved facial wrinkles, loss of firmness, and contour deficiencies associated with aging-related volume loss, with high patient satisfaction and sustained results.

Global Aesthetic Medicine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global aesthetic medicine market report based on procedure, end use, and region:

• Procedure Outlook (Revenue, USD Million, 2021 - 2033)
• Invasive Procedures
  • Breast augmentation
  • Liposuction
  • Nose reshaping
  • Eyelid Surgery
  • Tummy tuck
  • Others
• Non-invasive Procedures
  • Botox injections
  • Soft tissue fillers
  • Chemical peel
  • Laser hair removal
  • Microdermabrasion
  • Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Clinics & Aesthetic Centers
• Medspas
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources & Third-Party Perspectives
  • 1.3.4. Primary Research
  • 1.3.5. Details of Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
  • 1.5.1. Commodity Flow Analysis
• 1.6. Data Validation & Publishing
• 1.7. List of Secondary Sources
• 1.8. Research Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segmental Snapshot
• 2.3. Competitive Insights Snapshot

Chapter 3. Market Variables, Trends, and Scope

• 3.1. Market Lineage
  • 3.1.1. Parent Market Analysis
  • 3.1.2. Ancillary Market Analysis
• 3.2. Aesthetic Medicine Market - Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Adoption of Aesthetic Procedures Among Men
    • 3.2.1.2. Increased Social Media Influence Shaping Beauty Standards
    • 3.2.1.3. Growing Geriatric Population Driving Demand for Anti-Aging Aesthetic Treatments
• 3.3. Rising Demand for Minimally Invasive Procedures
  • 3.3.1. Market Restraint Analysis
    • 3.3.1.1. Stringent regulatory framework
    • 3.3.1.2. Complications related to liposuction and postoperative complications related to nose reshaping
• 3.4. Patient Perspective Analysis
  • 3.4.1. Consumer behavior analysis
  • 3.4.2. Market influencer analysis
• 3.5. Number of Plastic Surgeons in 2025
• 3.6. Major Deals & Strategic Alliances Analysis
• 3.7. Business Environmental Tools Analysis: Aesthetic Medicine Market
  • 3.7.1. Porter's Five Forces Analysis
  • 3.7.2. PESTLE Analysis

Chapter 4. Aesthetic Medicine Market: Procedure Estimates & Trend Analysis

• 4.1. Aesthetic Medicine Market, By Procedure: Key Takeaways
• 4.2. Aesthetic Medicine Market: Procedure Movement & Market Share Analysis, 2025 & 2033
• 4.3. Invasive Procedures
  • 4.3.1. Invasive Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.2. Breast Augmentation
    • 4.3.2.1. Breast Augmentation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.3. Liposuction
    • 4.3.3.1. Liposuction Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.4. Nose Reshaping
    • 4.3.4.1. Nose Reshaping Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.5. Eyelid Surgery
    • 4.3.5.1. Eyelid Surgery Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.6. Tummy Tuck
    • 4.3.6.1. Tummy Tuck Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3.7. Others
    • 4.3.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Non-invasive Procedures
  • 4.4.1. Non-invasive Procedures Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Botox Injections
    • 4.4.2.1. Botox Injections Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Soft Tissue Fillers
    • 4.4.3.1. Soft Tissue Fillers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.4. Chemical Peel
    • 4.4.4.1. Chemical Peel Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.5. Laser Hair Removal
    • 4.4.5.1. Laser Hair Removal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.6. Microdermabrasion
    • 4.4.6.1. Microdermabrasion Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4.7. Others
    • 4.4.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Aesthetic Medicine Market: End use Estimates & Trend Analysis

• 5.1. Aesthetic Medicine Market, By End use: Key Takeaways
• 5.2. Aesthetic Medicine Market: End use Movement & Market Share Analysis, 2025 & 2033
• 5.3. Hospitals
  • 5.3.1. Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Clinics & Aesthetic Centers
  • 5.4.1. Clinics & Aesthetic Centers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Medspas
  • 5.5.1. Medspas Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Aesthetic Medicine Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2025 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. North America
  • 6.4.1. U.S.
    • 6.4.1.1. Key country dynamics
    • 6.4.1.2. Regulatory framework
    • 6.4.1.3. Competitive scenario
    • 6.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.4.2. Canada
    • 6.4.2.1. Key country dynamics
    • 6.4.2.2. Regulatory framework
    • 6.4.2.3. Competitive scenario
    • 6.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.4.3. Mexico
    • 6.4.3.1. Key country dynamics
    • 6.4.3.2. Regulatory framework
    • 6.4.3.3. Competitive scenario
    • 6.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.5. Europe
  • 6.5.1. UK
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5.2. Germany
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5.3. France
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5.4. Italy
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5.5. Spain
    • 6.5.5.1. Key country dynamics
    • 6.5.5.2. Regulatory framework
    • 6.5.5.3. Competitive scenario
    • 6.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5.6. Norway
    • 6.5.6.1. Key country dynamics
    • 6.5.6.2. Regulatory framework
    • 6.5.6.3. Competitive scenario
    • 6.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5.7. Sweden
    • 6.5.7.1. Key country dynamics
    • 6.5.7.2. Regulatory framework
    • 6.5.7.3. Competitive scenario
    • 6.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5.8. Denmark
    • 6.5.8.1. Key country dynamics
    • 6.5.8.2. Regulatory framework
    • 6.5.8.3. Competitive scenario
    • 6.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Japan
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6.2. China
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6.3. India
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6.4. Australia
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6.6. Thailand
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Singapore market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.7. Latin America
  • 6.7.1. Brazil
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7.2. Argentina
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.8. MEA
  • 6.8.1. South Africa
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8.2. Saudi Arabia
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8.3. UAE
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Competitive scenario
    • 6.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8.4. Kuwait
    • 6.8.4.1. Key country dynamics
    • 6.8.4.2. Regulatory framework
    • 6.8.4.3. Competitive scenario
    • 6.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Key company market position analysis, 2025
• 7.4. List of Companies
  • 7.4.1. The Cosmetic Clinic (SILK Laser Australia Limited)
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Service benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Therapie Clinic /Valterous Limited.
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Service benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. SKINnovative
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Service benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Shea Aesthetic Clinic
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Service benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Sisu Clinic
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Service benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. THE BANGKOK COSMETIC CLINIC
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Service benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Cutis Medical Laser Clinics
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Service benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. Grand Plastic Surgery
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Service benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. MUSE CITY CLINIC
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Service benchmarking
    • 7.4.9.4. Strategic initiatives
  • 7.4.10. The Esthetic Clinics
    • 7.4.10.1. Company overview
    • 7.4.10.2. Financial performance
    • 7.4.10.3. Service benchmarking
    • 7.4.10.4. Strategic initiatives